a year ago
ACN
AnalystsJonathan LeeJonathan Lee's Stock Forecasts
AnalystsJonathan Lee
Analyst Ranking
Bottom 2%
#4956 out of 5018 analysts
Average Return
-29.92%
Win Rate
7%2 out of 27
Risk vs Reward
Poor
Good
Jonathan Lee Analyst Color
Get additional color on Jonathan Lee's coverage of popular stocks
Jonathan Lee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Endava PLCDAVA | 9 | Strong Buy | $18.00 | +86.92% | Maintains | 13 days ago |
Cognizant Technology Solutions CorpCTSH | 2 | Strong Buy | $90.00 | +30.11% | Upgrades | 2 months ago |
Accenture PLCACN | 7 | Strong Buy | $335.00 | +41.46% | Maintains | 3 months ago |
Globant SaGLOB | 6 | Strong Buy | $125.00 | +120.07% | Reiterates | 3 months ago |
Epam Systems IncEPAM | 3 | Strong Buy | $215.00 | +39.10% | Maintains | 4 months ago |
Telus International IncTIXT | 1 | Hold | $9.00 | N/A | Initiates Coverage On | a year ago |
DXC Technology CoDXC | 1 | Hold | $22.00 | N/A | Initiates Coverage On | a year ago |
Taskus IncTASK | 1 | Hold | $13.00 | N/A | Initiates Coverage On | a year ago |
Infosys LtdINFY | 1 | Hold | $20.00 | N/A | Initiates Coverage On | a year ago |
Perficient IncPRFT | 5 | Hold | $65.00 | N/A | Initiates Coverage On | a year ago |
Ttec Holdings IncTTEC | 1 | Strong Sell | $8.00 | N/A | Initiates Coverage On | a year ago |
Ptc Therapeutics IncPTCT | 1 | Hold | $40.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.